Literature DB >> 15796203

Cytotoxicity and radical modulating activity of Moxa smoke.

Hiroshi Sakagami1, Hisatoshi Matsumoto, Kazue Satoh, Seiji Shioda, Chowdhury Shahead Ali, Ken Hashimoto, Hirotaka Kikuchi, Hirofumi Nishikawa, Shigemi Terakubo, Yoko Shoji, Hideki Nakashima, Jun Shimada.   

Abstract

The biological activities of Moxa, used as moxibustion, have not been well documented. We investigated here Moxa smoke for its tumor-specific cytotoxicity, anti-HIV activity, radical intensity and radical scavenging activity, in comparison with previously published data of Moxa extract. Moxa smoke showed slightly higher cytotoxicity against human tumor cell lines (oral squamous cell carcinoma HSC-2, HSC-3, promyelocytic leukemia HL-60) than against normal oral cells (gingival fibroblast HGF, pulp cell HPC, periodontal ligament fibroblast HPLF), yielding a tumor specificity index of 1.29. Moxa smoke dose-dependently induced internucleosomal DNA fragmentation, activation of caspases 3, 8 and 9, and slightly modified the expression of apoptosis-related proteins (Bcl-2, Bad, Bax) in HL-60 cells, but to much lesser extents than attained by positive controls (UV irradiation, actinomycin D treatment). ESR spectroscopy showed that Moxa smoke generated semiquinone-type radicals under alkaline conditions, and scavenged O2(-), hydroxyl radical, singlet oxygen and NO. All Moxa smoke preparations showed no apparent anti-HIV activity. These data demonstrate the antitumor potential of Moxa smoke.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15796203

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  7 in total

1.  The effect of different laser irradiation on cyclophosphamide-induced leucopenia in rats.

Authors:  Jizhong Zhao; Ke Cheng; Haiping Deng; Ling Zhao; Lanlan Liu; Menghu Guo; Haimeng Zhang; Xueyong Shen
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-14       Impact factor: 2.629

2.  Bibliometric Analysis of Moxibustion Research Trends over the Past 20 Years.

Authors:  Hyejin Park; In-Seon Lee; Hyangsook Lee; Younbyoung Chae
Journal:  J Clin Med       Date:  2020-04-26       Impact factor: 4.241

3.  The Mechanism Study of Moxa Combustion Products on Regulating Vascular Endothelial Function in Atherosclerotic Mice.

Authors:  Huang Yueping; Yao Qin; OuYang Xiali; Lin Yao; Liu Yajie; Huang Chang; He Rui; Hui Xin; Wang Hao; Zhang Rui; Liu Jinyi; Zhao Baixiao
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-03       Impact factor: 2.650

4.  How does moxibustion possibly work?

Authors:  Jen-Hwey Chiu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-27       Impact factor: 2.629

5.  Effects of Moxa Smoke on Monoamine Neurotransmitters in SAMP8 Mice.

Authors:  Huanfang Xu; Baixiao Zhao; Yingxue Cui; Min Yee Lim; Ping Liu; Li Han; Hongzhu Guo; Lixing Lao
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-13       Impact factor: 2.629

6.  Safety recommendations for moxa use based on the concentration of noxious substances produced during commercial indirect moxibustion.

Authors:  O Sang Kwon; Seong Jin Cho; Kwang-Ho Choi; Sun Hee Yeon; Suk-Yun Kang; Jae-Hyo Kim; Seong-Hun Ahn; Yeonhee Ryu
Journal:  Acupunct Med       Date:  2016-08-11       Impact factor: 2.267

7.  Analysis of the Components in Moxa Smoke by GC-MS and Preliminary Discussion on Its Toxicity and Side Effects.

Authors:  Xiaoyu Xu; Si Shan; Wenlei Wang; Hongning Liu
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-31       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.